Drug-induced cholestasis

Erlinger, 1996, New insights into the mechanisms of hepatic transport and bile secretion, J Gastroenterol Hepatol, 11, 575, 10.1111/j.1440-1746.1996.tb01705.x Larrey, 1988, Drug-induced cholestasis, 2, 423 Stricker, 1992 Kowdley, 1992, Prolonged cholestasis due to trimethoprim-sulfamethoxazole, Gastroenterology, 106, 2148, 10.1016/0016-5085(92)90346-Z Degott, 1992, Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia, Hepatology, 15, 244, 10.1002/hep.1840150212 Larrey, 1993, Pathologie biliaire liée aux médicaments, Gastroenterol Clin Biol, 17, H59 Davies, 1994, Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis, J Hepatol, 20, 112, 10.1016/S0168-8278(05)80476-3 Moradpour, 1994, Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis, Hepatology, 20, 1437, 10.1002/hep.1840200610 Koek, 1994, Flucloxacillin-associated hepatic injury, Liver, 14, 225, 10.1111/j.1600-0676.1994.tb00079.x Devereaux, 1995, Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?, Eur J Clin Pharmacol, 49, 81 Ryley, 1995, Focal destructive cholangiopathy associated with amoxycillin/clavulanic acid (Augmentin®), J Hepatol, 23, 278